Results 111 to 120 of about 4,843,979 (151)

Restoration of lysosomal membrane integrity in cell models of Pompe disease depends on fatty acid synthase and its product palmitic acid. [PDF]

open access: yesCell Mol Biol Lett
Le Guillou E   +12 more
europepmc   +1 more source

Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets. [PDF]

open access: yesNat Rev Neurol
Ziółkowska EA   +5 more
europepmc   +1 more source

SARS-CoV-2 intra-host viral diversity associated with host innate and vaccine-induced immunity in an obese mouse model. [PDF]

open access: yesBMC Infect Dis
Song W   +15 more
europepmc   +1 more source

Management Strategies for CLN2 Disease [PDF]

open access: yesPediatric Neurology, 2017
CLN2 disease (neuronal ceroid lipofuscinosis type 2) is a rare, autosomal recessive, pediatric-onset, rapidly progressive neurodegenerative lysosomal storage disorder caused by tripeptidyl peptidase 1 (TPP1) enzyme deficiency, and is characterized by ...
Boris Zernikow   +2 more
exaly   +6 more sources

Managing CLN2 disease: a treatable neurodegenerative condition among other treatable early childhood epilepsies [PDF]

open access: yesExpert Review of Neurotherapeutics, 2021
Introduction : Neuronal ceroid lipofuscinosis type 2 (CLN2 disease) is a rare pediatric neurodegenerative condition, which is usually fatal by mid-adolescence.
Igor Prpic   +2 more
exaly   +6 more sources

Home - About - Disclaimer - Privacy